|
Name: Alpha-ethyltryptamine
Type: Psychedelic tryptamine
AKA: ET, Trip
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Alpha-Ethyltryptamine, a tryptamine derivative, was studied in the 1970s. It is known for its psychoactive effects and has been researched for its potential in psychoactive therapy. Its use is regulated due to its potent effects and potential for abuse.
|
|
V. Legal Information
Alpha-Ethyltryptamine, a psychoactive compound, is often regulated under analog laws due to its psychoactive effects. Its legal status varies by jurisdiction.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Alpha-Ethyltryptamine is a psychoactive compound with hallucinogenic properties. As an upper, it induces altered perception and euphoria. Short-term effects include visual and auditory distortions, while long-term use may lead to psychological issues. Overdose risks involve severe agitation and hallucinations. Safe use involves cautious dosing, and recent research highlights its effects and potential risks.  |
|
VII. Psychological Effects
Alpha-ethyltryptamine, a psychedelic, affects serotonin receptors, leading to altered perception and cognition. Immediate effects include euphoria and hallucinations, with effects lasting several hours. Long-term use can lead to persistent changes in perception and mood swings. Recent research indicates risks of psychological disturbances with frequent use.
 |
|
VIII. Culture
Alpha-ethyltryptamine (AET) is a psychoactive drug with stimulant and hallucinogenic effects, classifying it as an upper. Short-term use induces euphoria, increased energy, and altered perception, while long-term use poses risks of neurotoxicity and psychological dependence. Overdose can result in severe agitation, hyperthermia, and cardiovascular complications. Safe dosages range from 10-20 mg. Recent research highlights its potential therapeutic uses and abuse risks. Physical signs include dilated pupils, increased heart rate, and elevated blood pressure.
 |